Header Logo

Connection

KYLE EAGEN to Cell Line, Tumor

Back to Details
This is a "connection" page, showing publications KYLE EAGEN has written about Cell Line, Tumor.
KYLE EAGEN
Connection Strength
0.131
Cell Line, Tumor
  1. Supercharging BRD4 with NUT in carcinoma. Oncogene. 2021 02; 40(8):1396-1408.
    View in: PubMed
    Score: 0.101
  2. EZH2 Cooperates with BRD4-NUT to Drive NUT Carcinoma Growth by Silencing Key Tumor Suppressor Genes. Cancer Res. 2023 12 01; 83(23):3956-3973.
    View in: PubMed
    Score: 0.031
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.